Larvol Delta - Phase-12a-Clinical-Trial-of-PR001-LY3884961-in-Patients-With-Parkinson39s-Disease-With-at-Least-One-GBA1-Mutation-PROPEL

sirolimus - Generic mfg.

LY3884961 - Eli Lilly

http://clinicaltrials.gov/ct2/show/NCT04127578

Sep 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next